Trials / Completed
CompletedNCT01168414
A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Randomized, Comparison of the Effects of Ganfort and Duotrav on Intraocular Pressure in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Open Label/Evaluator-blind/Cross-over Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Ministry of Health, Malaysia · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a single-center, cross-over comparison parallel group randomized trial designed to evaluate the efficacy and safety of Ganfort compared to Duotrav for a treatment period of 8 weeks each.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ganfort | Fixed combination of Bimatoprost and Timolol (BTFC; Ganfort (300 microgram + 5 mg/ml eyedrops solution) |
| DRUG | Duotrav | Fixed combination of Travoprost and Timolol (TTFC; Duotrav (40 micrograms + 5 mg/ml eyedrops solution) |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2011-01-01
- Completion
- 2011-02-01
- First posted
- 2010-07-23
- Last updated
- 2011-07-08
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT01168414. Inclusion in this directory is not an endorsement.